Status:
COMPLETED
Evaluation of Microvolt T-Wave Alternans(MTWA) Testing for the Detection of Active Ischemia
Lead Sponsor:
Cambridge Heart Inc.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
MTWA-CAD is a feasibility study designed to evaluate Microvolt T-Wave Alternans (MTWA) testing for the purpose of detecting active ischemia in patients with known or suspected coronary artery disease ...
Detailed Description
Ischemia, a common trigger for arrhythmias, is a well-documented cause of repolarization alternans. Human studies have shown that active ischemia can be associated with visible as well as microvolt-le...
Eligibility Criteria
Inclusion
- Age 18 or above, or of legal age to give informed consent specific to state and national law
- Willing and capable of providing informed consent
- Willing and capable of undergoing a SPECT MPI exercise test (or stress echo) at an approved clinical investigational center
- In normal sinus rhythm at the time of the exercise test
- A life expectancy of more than 6 months
Exclusion
- In atrial fibrillation at the time of the exercise test
- Left bundle branch block (precludes ST segment measurement)
- Pacemaker-dependent
- Life expectancy of less than 6 months
- Pregnancy
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT01174797
Start Date
June 1 2010
End Date
May 1 2013
Last Update
May 27 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Connecticut Clinical Research, LLC
Bridgeport, Connecticut, United States, 06606
2
Northwest Houston Heart Center
Tomball, Texas, United States, 77375